Van Eck Associates Corp Abiomed Inc Transaction History

Van Eck Associates Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$242.49 - $301.46 $80,506 - $100,084	332 Added 5.64%	6,216 $1.53 Million
Q2 2022 Aug 03, 2022	BUY	$224.73 - $338.64 $94,386 - $142,228	420 Added 7.69%	5,884 $1.46 Million
Q1 2022 May 10, 2022	BUY	$277.25 - $366.29 $148,883 - $196,697	537 Added 10.9%	5,464 $1.81 Million
Q4 2021 Jan 26, 2022	BUY	$300.63 - $371.35 $251,627 - $310,819	837 Added 20.46%	4,927 $1.77 Million
Q3 2021 Nov 03, 2021	BUY	$310.19 - $376.2 $109,186 - $132,422	352 Added 9.42%	4,090 $1.33 Million
Q2 2021 Aug 10, 2021	BUY	$262.71 - $351.17 $982,009 - $1.31 Million	3,738 New	3,738 $1.17 Million
Q2 2020 Aug 10, 2020	SELL	$141.4 - $257.09 $318,574 - $579,223	-2,253 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$130.51 - $196.01 $27,407 - $41,162	210 Added 10.28%	2,253 $327,000
Q4 2019 Feb 13, 2020	BUY	$159.31 - $223.54 $325,470 - $456,692	2,043 New	2,043 $349,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.